Cutler Group’s 10x Genomics TXG Stock Holding History

Cutler Group’s Portfolio TXG Stock Details TXG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-2,300	Closed	-$4K	–	4740
2022 Q4	$4K	Hold	2,300	–	–	﹤0.01%	3376
2022 Q3	$16K	Buy	+2,300	New	+$87.6K	﹤0.01%	2783
2022 Q2	–	Sell	-5,400	Closed	-$7K	–	5694
2022 Q1	$7K	Buy	+5,400	New	+$472K	﹤0.01%	3921
2021 Q1	–	Sell	-5,200	Closed	-$46K	–	6312
2020 Q4	$46K	Buy	5,200 +4,400	+550%	+$639K	﹤0.01%	2079
2020 Q3	$7K	Buy	+800	New	+$84K	﹤0.01%	3278

Other funds holding TXG

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

BCM

Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return

SIM

SRS Investment Management New York $9.47B AUM 60.12% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Cutler Group's TXG Position: Q1 2023 in Review

Cutler Group sold out of 10x Genomics (TXG) in Q1 2023, closing a stake of 2,300 shares — an estimated $83K sold.

Cutler Group first reported a position in TXG in Q4 2019 and held it in 11 quarters. The position peaked at $512K in Q4 2020. 258 funds tracked by Wall St. Rank hold TXG as of Q1 2023.

Cutler Group reported no remaining 10x Genomics position as of Q1 2023 after selling out during the quarter.
Cutler Group sold 2,300 10x Genomics shares in Q1 2023, an estimated $83K.
Cutler Group first reported a position in 10x Genomics in Q4 2019 and held it in 11 quarters.
Cutler Group's 10x Genomics position peaked at $512K in Q4 2020.
258 funds tracked by Wall St. Rank held 10x Genomics as of Q1 2023.

Based on Cutler Group's 13F filing for Q1 2023, filed 1 May 2023.